JOURNAL OF MOLECULAR NEUROSCIENCE
Scope & Guideline
Unraveling the Complexities of the Nervous System
Introduction
Aims and Scopes
- Molecular Mechanisms of Neurological Disorders:
The journal explores the intricate molecular pathways involved in various neurological disorders, including Alzheimer's disease, Parkinson's disease, schizophrenia, and autism spectrum disorders. This encompasses genetic, epigenetic, and signaling pathways that contribute to disease pathology. - Neuroprotection and Neuroregeneration:
Research articles focus on strategies aimed at protecting neurons from damage and enhancing regeneration following injury. This includes studies on neuroprotective agents, stem cell therapy, and the role of neurotrophic factors in promoting neuronal survival and repair. - Translational Research:
The journal emphasizes the importance of translating basic scientific discoveries into clinical applications, aiming to bridge the gap between laboratory research and patient care. This includes the development of biomarkers for diagnosis and prognosis, as well as novel therapeutic interventions. - Neuroinflammation and Immune Response:
Papers often discuss the role of inflammation in neurological diseases, examining how immune responses can exacerbate or mitigate neurodegeneration. This includes studies on microglial activation, cytokine profiles, and the impact of the gut-brain axis. - Psychobiotics and Gut-Brain Axis:
The journal investigates the relationship between gut microbiota and neurological health, exploring how alterations in gut microbiota composition can influence brain function and behavior through biochemical pathways. - Molecular Imaging and Biomarkers:
Research in this area focuses on the development and application of imaging techniques and biomarker identification for early diagnosis and monitoring of neurological diseases, facilitating personalized medicine approaches.
Trending and Emerging
- Multi-Omics Approaches:
There is a growing trend in utilizing multi-omics approaches, integrating genomics, proteomics, and metabolomics to gain comprehensive insights into the molecular underpinnings of neurological diseases. This trend allows researchers to identify complex interactions and potential biomarkers for diagnosis and treatment. - Role of Non-Coding RNAs:
The investigation of non-coding RNAs, such as microRNAs and long non-coding RNAs, has gained prominence. Research is increasingly focusing on their regulatory roles in gene expression and their potential as therapeutic targets or biomarkers in various neurological conditions. - Neuroinflammation as a Therapeutic Target:
Research emphasizing the role of neuroinflammation in the pathogenesis of neurological disorders is on the rise. Studies are exploring how modulating immune responses can lead to neuroprotection and improved outcomes in conditions like Alzheimer's and multiple sclerosis. - Gut-Brain Axis Research:
The relationship between gut microbiota and neurological health has emerged as a significant area of interest, reflecting a growing understanding of how gut health can influence brain function and behavior. This includes studies on psychobiotics and their effects on mental health. - Advanced Therapeutic Strategies:
Emerging therapies such as gene therapy, stem cell therapy, and novel pharmacological approaches are increasingly featured. Research is focusing on innovative strategies to promote neuroprotection and regeneration in neurodegenerative diseases.
Declining or Waning
- Traditional Pharmacological Approaches:
There is a noticeable decline in studies focused solely on traditional pharmacological treatments for neurological disorders without considering molecular mechanisms or novel therapeutic strategies. This shift may reflect a growing interest in understanding the underlying biology rather than just treatment efficacy. - Animal Models of Disease Without Genetic Insights:
Research relying heavily on classical animal models without incorporating genetic or molecular insights has decreased. The trend seems to favor studies that integrate molecular analyses and genetic profiling to provide a more comprehensive understanding of disease mechanisms. - Basic Neuroanatomy Studies:
Basic studies focusing solely on neuroanatomy without linking findings to molecular or pathological implications appear to be waning, as the field moves towards more integrative approaches that combine anatomy with molecular and functional insights. - Single-Factor Studies:
There is a trend away from studies that examine the effects of a single factor (e.g., one drug or one gene) in isolation, as the complexity of neurological disorders necessitates a more holistic approach incorporating multiple factors and interactions.
Similar Journals
BRAIN RESEARCH BULLETIN
Shaping the future of neuroscience through impactful research.BRAIN RESEARCH BULLETIN is a leading academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to the dissemination of high-quality research in the interdisciplinary field of neuroscience. Since its inception in 1976, this journal has served as a vital platform for researchers, professionals, and students interested in a broad spectrum of topics within neuroscience, making significant contributions to the understanding of brain function and its associated disorders. With a commendable impact factor and a current Scopus rank of #35 out of 113 in general neuroscience, the journal holds a Q2 quartile ranking, underscoring its relevance and influence in the academic community. BRAIN RESEARCH BULLETIN invites submissions of original articles, reviews, and brief communications, enhancing scholarly communication within this dynamic field. Although the journal is not open access, it ensures widespread reach and impact through various subscription models, allowing access to pivotal findings that pave the way for future research advancements. For researchers aiming to share impactful discoveries and insights within the neuroscience community, BRAIN RESEARCH BULLETIN remains an essential outlet.
Acta Neuropathologica Communications
Transforming Neurological Understanding Through Research.Acta Neuropathologica Communications is a distinguished open-access journal published by BMC since 2013, focusing on the rapidly advancing fields of neurology, cellular and molecular neuroscience, and pathology. Located in the United Kingdom, this journal serves as a vital platform for researchers to disseminate significant findings that enhance our understanding of neurological disorders and their underlying mechanisms. With an impressive impact factor reflected in its Q1 ranking across multiple relevant categories, including Cellular and Molecular Neuroscience, Neurology (Clinical), and Pathology and Forensic Medicine, Acta Neuropathologica Communications stands out in the academic community for its rigorous peer-review process and commitment to high-quality research. The journal’s Scopus rankings highlight its global relevance, placing it in the top percentiles among leading research publications. Researchers, professionals, and students alike are encouraged to access and contribute to this essential resource, fostering a collaborative and informed approach to tackling the complexities of neuropathology and neuroscience.
NEUROMOLECULAR MEDICINE
Transforming Understanding of Nervous System DiseasesNEUROMOLECULAR MEDICINE, published by HUMANA PRESS INC, is a prestigious peer-reviewed journal dedicated to advancing the fields of cellular and molecular neuroscience, molecular medicine, and neurology. With an ISSN of 1535-1084 and an E-ISSN of 1559-1174, the journal boasts a significant presence in academic research since its inception in 2002 and continues to publish cutting-edge studies through 2024. Ranked in the Q2 category for 2023 in various disciplines, including Neuroscience and Molecular Medicine, it holds impressive positions in Scopus rankings, including 41st out of 192 in Neuroscience and Neurology. Although not an open access journal, NEUROMOLECULAR MEDICINE remains invaluable for researchers, professionals, and students seeking to explore the intricate relationships between molecular mechanisms and neurological functions, thereby contributing to the scientific understanding of nervous system diseases and therapeutic innovations.
TRENDS IN NEUROSCIENCES
Advancing Knowledge in Neural ProcessesTRENDS IN NEUROSCIENCES, published by CELL PRESS, is a leading journal in the field of neuroscience, offering cutting-edge insights and important developments in the rapidly evolving landscape of brain research. With an impressive Impact Factor and ranking in the top quartile (Q1) of the category for Neuroscience (miscellaneous), it is positioned as a vital resource for researchers and professionals seeking to stay abreast of the latest discoveries and trends from 1978 to the present. Specifically ranked #3 out of 113 in General Neuroscience by Scopus, this journal promotes the interdisciplinary exchange of ideas and knowledge, making it an essential platform for students and experienced scholars alike. Although it is not an Open Access journal, its value lies in its rigorous peer-review process and commitment to maintaining the highest standards of academic integrity. By continuing to explore the complexities of neural processes and behavior, TRENDS IN NEUROSCIENCES plays a crucial role in shaping the future of neuroscience research and education.
NEUROCHEMISTRY INTERNATIONAL
Advancing the Frontiers of Neurochemical ResearchNEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.
NEUROBIOLOGY OF DISEASE
Unlocking the Mysteries of Neurological DisordersNEUROBIOLOGY OF DISEASE is a premier journal dedicated to advancing the understanding of neurological disorders and the underlying biological processes, published by Academic Press Inc, Elsevier Science. With an impressive impact factor indicative of its significance—ranked in the Q1 quartile in Neurology for 2023 and occupying the 14th rank out of 192 journals in the field of Neuroscience and Neurology—this journal serves as a critical resource for researchers, clinicians, and students alike. The journal has a rich history since its inception in 1994, continuously evolving its scope to encompass groundbreaking research and insights into neurobiological mechanisms and disease pathology. Though it currently does not provide Open Access options, NEUROBIOLOGY OF DISEASE remains a vital vessel for disseminating knowledge that significantly contributes to the field of neurology, fostering an understanding that can lead to innovative therapeutic strategies.
MOLECULAR NEUROBIOLOGY
Exploring the Molecular Foundations of NeurologyWelcome to Molecular Neurobiology, the premier journal dedicated to the exploration of the molecular mechanisms underlying nervous system function and pathophysiology. Published by Springer, this journal provides an essential platform for disseminating high-quality research in the rapidly evolving fields of Cellular and Molecular Neuroscience and Neurology, boasting an impressive impact factor that reflects its esteemed position within the academic community. With its ranking in the Q1 and Q2 quartiles for various neuroscience categories, Molecular Neurobiology stands at the forefront of groundbreaking discoveries, showcasing innovative studies that bridge basic science and clinical application. Researchers and professionals are invited to contribute to its rich portfolio, which spans from fundamental insights into cellular processes to advanced therapeutic strategies. Although Molecular Neurobiology does not operate as an Open Access journal, its influential body of work remains accessible through institutional and personal subscriptions. As we converge from 1987 to 2024, we continue to aim for excellence, seeking to catalyze progress in understanding neurological diseases and enhance the scientific dialogue within the neuroscience community.
NEUROSCIENTIST
Illuminating the Path to Neurological BreakthroughsNEUROSCIENTIST is a leading journal in the field of clinical neurology and neuroscience, published by SAGE Publications Inc. With an impressive impact factor reflected in its Q1 quartile ranking in both clinical neurology and miscellaneous neuroscience as of 2023, this journal positions itself as a crucial platform for the latest research and advancements in the neural sciences. Spanning from 1995 to 2024, NEUROSCIENTIST features a range of high-quality, peer-reviewed articles that cater to researchers, practitioners, and students alike. Although it does not offer Open Access options, the journal remains a vital resource owing to its Scopus rankings, situating it within the top percentile of its categories: ranked #28 out of 400 in clinical neurology and #15 out of 113 in general neuroscience. The journal's commitment to disseminating significant findings underlines its importance in fostering advancements in neurological understanding and treatment.
Molecular Neurodegeneration
Advancing understanding of neurodegenerative diseases.Molecular Neurodegeneration is a leading journal published by BMC, dedicated to advancing the field of neurodegeneration through high-quality, open-access research. Since its inception in 2006, this peer-reviewed journal has provided a pivotal platform for the dissemination of innovative findings in the realms of Cellular and Molecular Neuroscience, Molecular Biology, and Clinical Neurology. With a stellar impact factor and listed in the prestigious Q1 category in multiple relevant categories, it ranks among the top publications in the field—specifically, it holds the #3 position in Neuroscience and #6 position in Clinical Neurology based on Scopus metrics. Researchers, professionals, and students alike will find significant value in the open access format, which fosters unrestricted sharing of knowledge, ensuring that emerging ideas in neurodegeneration reach a global audience. Based in London, United Kingdom, the journal promises a comprehensive scope that addresses critical questions in neurobiology, making it an essential resource for anyone interested in the molecular mechanisms underlying neurodegenerative diseases.
Journal of Central Nervous System Disease
Pioneering research for a healthier brain.Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.